Healthy volunteers needed for Early-Stage drug safety trial
NCT ID NCT07531628
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 4 times
Summary
This early-stage study tests the safety and how the body handles multiple doses of an experimental drug called verducatib in 12 healthy Chinese adults aged 18 to 55. Participants take the drug by mouth for 4 weeks. The goal is to gather information to support future development of verducatib in China, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, 310009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test